We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.7%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
3076
Trekor Metals
TGB
$3.05B
$350K ﹤0.01%
+248,216
New +$305K
FHTX icon
3077
Foghorn Therapeutics
FHTX
$360M
$348K ﹤0.01%
53,963
+483
+0.9% +$2.08K
SEER icon
3078
Seer Inc
SEER
$120M
$348K ﹤0.01%
179,279
+2,375
+1% +$4.22K
FEAM icon
3079
5E Advanced Materials
FEAM
$62.3M
$343K ﹤0.01%
10,567
+256
+2% +$12.5K
NN icon
3080
NextNav
NN
$2.23B
$342K ﹤0.01%
76,951
EXK
3081
Endeavour Silver
EXK
$2.83B
$341K ﹤0.01%
+172,991
New +$376K
SKE
3082
Skeena Resources
SKE
$4.04B
$339K ﹤0.01%
+69,241
New +$292K
RNAC icon
3083
Cartesian Therapeutics
RNAC
$268M
$338K ﹤0.01%
16,344
TEAD
3084
Teads Holding Co
TEAD
$66.9M
$338K ﹤0.01%
77,142
VUZI icon
3085
Vuzix
VUZI
$224M
$337K ﹤0.01%
161,744
+1,454
+0.9% +$3.96K
STRS icon
3086
Stratus Properties
STRS
$154M
$336K ﹤0.01%
11,628
+3,112
+37% +$84.7K
HPK icon
3087
HighPeak Energy
HPK
$910M
$335K ﹤0.01%
23,557
+2,238
+10% +$35.5K
NODK icon
3088
NI Holdings
NODK
$320M
$335K ﹤0.01%
25,786
+7,496
+41% +$95.7K
CWBC
3089
Community West Bancshares
CWBC
$684M
$334K ﹤0.01%
14,922
+2,095
+16% +$36.6K
STOK icon
3090
Stoke Therapeutics
STOK
$2.11B
$333K ﹤0.01%
63,331
+467
+0.7% +$2K
THRX
3091
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$332K ﹤0.01%
81,898
INGN icon
3092
Inogen
INGN
$164M
$329K ﹤0.01%
59,992
+471
+0.8% +$2.49K
NGMS
3093
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$329K ﹤0.01%
11,497
MAV
3094
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$326K ﹤0.01%
+40,709
New +$293K
IMRX icon
3095
Immuneering
IMRX
$292M
$324K ﹤0.01%
44,049
+3,504
+9% +$23.3K
PLSE icon
3096
Pulse Biosciences
PLSE
$2.94B
$323K ﹤0.01%
26,372
+3,607
+16% +$25K
MYD
3097
DELISTED
BlackRock MuniYield Fund
MYD
$322K ﹤0.01%
+29,862
New +$293K
III icon
3098
Information Services Group
III
$248M
$322K ﹤0.01%
68,263
SNPO
3099
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$321K ﹤0.01%
36,061
+350
+1% +$2.85K
INNV icon
3100
InnovAge Holding
INNV
$1.52B
$321K ﹤0.01%
53,437
+703
+1% +$4K

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.